SCHEMBL24310457

SCHEMBL24310457

CC(C)c1ccccc1-c1cc(Oc2cc(N3CCN(C)CC3)ccc2Cl)nc(NSc2cccc(N)c2)n1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 9/20 0.39
▸ EGFR P00533 4/20 0.39
▸ CDK9 P50750 3/20 0.35
▸ CDK6 Q00534 3/20 0.35
▸ CCNK O75909 2/20 0.35
▸ CCND3 P30281 2/20 0.35
▸ BRD2 P25440 1/20 0.34
▸ BRD3 Q15059 1/20 0.34
▸ ADRA2C P18825 1/20 0.33
▸ INSR P06213 1/20 0.33
▸ IGF1R P08069 1/20 0.33
▸ ALK Q9UM73 1/20 0.33
▸ CCNT1 O60563 1/20 0.33
▸ CDK4 P11802 1/20 0.33
▸ CCND1 P24385 1/20 0.33
▸ CDK11A Q9UQ88 1/20 0.33
▸ AXL P30530 1/20 0.32
▸ PTK2 Q05397 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309467 0.94 EGFR (0.37) BRD4EGFRCDK9CDK6CCNK
SCHEMBL24309593 0.90 KDM4E (0.33) BRD4EGFRCDK9CDK6CCNK
SCHEMBL24309230 0.88 EGFR (0.32) BRD4EGFR
SCHEMBL29566903 0.84 HTR1A (0.39) BRD4EGFRCDK9CDK6CCNT1
SCHEMBL24310456 0.84 HTR1A (0.39) BRD4EGFRCDK9CDK6CCNT1
SCHEMBL24309684 0.83 MET (0.34) EGFRADRA2CPTK2
SCHEMBL24309262 0.83 CDK2 (0.32) CDK9
SCHEMBL24310509 0.82 CDK2 (0.32) EGFRCDK9
SCHEMBL24309736 0.79 CDK2 (0.32) CDK9CDK4CCND1
SCHEMBL24309465 0.79 HTR6 (0.39) BRD4EGFRCDK9CDK6CCNK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback